Day Lewis Medical Ltd: UK Public Sector Contracts Won & Awards

Large organisationCompanies House: Private Limited CompanyCroydonNationwide (UK)Main market: Pharmaceutical products

Official UK PPONPPCN-4186-QCWHCompanies House01904504 ↗ · Active

Where they win
i

58 awards (56 for a named lot, 97%, 2 for a whole procedure with no lot named) · top CPV classes, shares of all 58 awards. An award may cover more than one class.

3360 Pharmaceutical products58 awards · 100% · 56 awards naming a lot + 2 whole-procedure awards
Attributable award value
i
£2.7mOn 2 of 58 award records; the five largest make 100%. Largest rows below.

Where their buyers are
i

ITL1 region of the buyer office · known for 44 of 44 awarded procedures · each procedure counts once

Greater London26 procedures · 59%
Scotland6 procedures · 14%
North West England5 procedures · 11%
South East England3 procedures · 7%
Wales (Cymru)2 procedures · 5%
Yorkshire and the Humber1 procedure · 2%
Northern Ireland1 procedure · 2%

Bidding record
i

Procurement Act 2023 award notices name every bidder · 6 notices name this supplier, covering 10 lots since 18 Dec 2025 · observed bids, not an estimate

Contract lots contested
i
0 won · 0 lostFewer than three decided lots: no rate is claimed.
Framework / DPS places
i
6 of 10Lots on 6 notices: a place is won per lot.
Authorities bid for
i
1
NoticeAuthorityOutcomeBiddersPublished
NHS National Generic Pharmaceuticals - Wave 16aframework/DPSNHS Englandappointed to 2 of 3 lots1259 Oct 2026
NHS National Generics Pharmaceuticals - Supply Chain Resilienceframework/DPSNHS Englandappointed to 1 of 2 lots416 Jul 2026
NHS National Branded Interim - 1 June 2026framework/DPSNHS Englandappointed5322 May 2026
NHS National Generic Pharmaceuticals - Wave 15cframework/DPSNHS Englandappointed11826 Feb 2026
NHS National Framework for Generics Housekeepingframework/DPSNHS Englandappointed to 1 of 2 lots5322 Dec 2025
NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Productsframework/DPSNHS Englandnot appointed1118 Dec 2025

Bidder names come from Procurement Act 2023 award notices, which list every bidder (from 2025). Older notices name no bidders, so earlier contests do not appear here. Latest ten notices shown.

Who they sell to
i

Authorities named on this supplier’s published awards · ranked by distinct procedures · a framework or DPS adds one award record per appointed supplier

Authority type · official UK type when published, else name/id class, else not classified · by award records (a single panel can dominate)
i
  • NHS & health97%(56 awards)
    56 of 58 awards are NHS & health (97%).
  • Type not classified3%(2 awards)
    2 of 58 awards are Type not classified (3%).
AuthorityProceduresShareAward recordsLast activity
NHS Englandframework/DPS on 232659.1%3327 Aug 2026
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")framework/DPS on 6613.6%177 Apr 2025
The NHS Commissioning Board (operating under the name of NHS England)framework/DPS on 5511.4%1330 Nov 2021
ATAMIS LTD36.8%37 Jul 2023
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)24.5%213 Jun 2025
Business Services Organisation Procurement and Logistics Serviceframework/DPS on 112.3%25 Jan 2026
NHS England and NHS Improvement12.3%119 Jul 2022

Share = of the 44 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.

Contracts ending
i

60 of 71 awards carry an end date, 22 estimated from the duration · not a retender forecast

ContractEndsPublished value
Ifosfamide Injection Powder For Reconstitution3 Jan 2027 estimated£461,565 ceiling
Range of Generic Cancer Medicines (single supplier)3 Jan 2027 estimated£3,432,063 ceiling
Generic Drugs - Tablets & Capsules31 Jan 2027£187,660
Wave 15a - Hospital Only Products (DNW & DLN regions)31 Jan 2027£1 ceiling
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)31 May 2027Not published
Wave 14c - Orals (plus non-parenteral) Products (all regions)31 May 2027£1 ceiling
NHS National Framework for Generics Housekeeping Lot 1 - Oral Products31 May 2027£17,843,324 ceiling
Wave 15b - Hospital Only DCE & DSW regions30 Sept 2027£1 ceiling
All Other Cardiovascular & Respiratory Medicines21 Mar 2028 estimated£24,410,075 ceiling
Enoxaparin Sodium Injection21 Mar 2028 estimated£9,947,020 ceiling

Soonest 10 of 14.

Recent awards

Latest 30 of 58 award records naming this supplier

Contracts Finder adds 13 more procedures won by this supplier, mostly below the Find a Tender threshold or from before 2025. Each is counted once beside any Find a Tender copy; they are in the totals, not in this list.

Award / procedureAuthorityAwardedPublished value
All Other Cardiovascular & Respiratory MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£24,410,075 †
framework ceiling · 1 of 33 appointed suppliers
Enoxaparin Sodium InjectionThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£9,947,020 †
framework ceiling · 1 of 4 appointed suppliers
Diltiazem Hydrochloride Modified-Release (M/R) Capsules and TabletsThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£81,720 †
framework ceiling · 1 of 4 appointed suppliers
Branded and Branded Generic InhalersThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£2,961,460 †
framework ceiling · 1 of 12 appointed suppliers
NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025NHS EnglandNot published£1 †
framework ceiling · not attributable revenue
Ifosfamide Injection Powder For ReconstitutionThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£461,565 †
framework ceiling · not attributable revenue
Range of Generic Cancer Medicines (single supplier)The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£3,432,063 †
framework ceiling · 1 of 24 appointed suppliers
Wave 15a - Hospital Only Products (DNW & DLN regions)NHS EnglandNot published£1 †
framework ceiling · not attributable revenue
NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024NHS EnglandNot published£1 †
framework ceiling · not attributable revenue
Wave 14c - Hospital Only Products DLS & DNE regionsNHS EnglandNot published£1 †
framework ceiling · not attributable revenue
About this data
  • One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
  • Values are published values. The table mirrors what the notice published: framework ceilings and joint awards are labelled and never counted as this supplier's money, and † marks a value taken from the contract notice when the award published none. Only awards made to this supplier alone count towards its value, excluding VAT. It is not turnover.
  • Regions in the buyer chart describe the buyer office, not where the work is delivered or the supplier’s registered address.
  • Contract end dates. Published on 38 of 71 awards, estimated from the published duration on 22 more (marked “estimated”); those feed “Contracts ending”. Published values in that list come from either source; Contracts Finder figures are shown as published and stay out of this profile’s money totals.
  • Source. Official UK public procurement notices (Find a Tender, Contracts Finder and Public Contracts Scotland), reused under the Open Government Licence v3.0, updated through the day and rebuilt nightly. Not every figure uses every feed, and each one shows how many records it rests on: see the methodology. Spotted something wrong? Tell us.